Description
Cartalax
A peptide bioregulator studied in research protocols focused on cartilage support, connective tissue regeneration, and broader restorative applications.
Product Overview
- Peptide: Cartalax
- Strength: 25 mg per vial
- Injection type: Subcutaneous or IM
- Frequency: 5 to 7 days per week for 10 to 20 days
Reconstitution
Amount in vial: 25 mg
BAC water: 2.5 mL
Amount per unit: 0.1 mg per unit
Recommended Dose
2 mg to 5 mg
Equivalent to 20 to 50 units
Notes
Subcutaneous or IM injection. Do not use if pregnant or breastfeeding. Research notes include blood pressure monitoring in patients with heart disease.
Disclaimer
This product is intended for research and informational purposes only.
Reviews
There are no reviews yet.